Poland – Pharmaceutical products – Supply of medicines for drug programs for the SP ZOZ in Kędzierzyn-Koźle – 13 tasks

Opportunity description

The subject of the contract is the supply of medicines for drug programs for the SP ZOZ in Kędzierzyn-Koźle – 13 tasks. A detailed description of the subject of the contract is contained in Annexes No. 2/1 – 2/13 to the SWZ. The parameters described therein constitute the minimum quality and technical requirements for the assortment being ordered. The contract has been divided into the following partial tasks: partial task No. 1 – Supply of Ocrevus– according to Annex No. 2/1 to the SWZ; partial task No. 2 – Supply of Metalyse – according to Annex No. 2/2 to the SWZ; partial task No. 3 – Supply of Bevacyzumab – according to Annex No. 2/3 to the SWZ; partial task No. 4 – Supply of Aflibercept – solution for injection 40 mg/ml – according to Annex No. 2/4 to the SWZ; partial task No. 5 – Supply of Aflibercept – solution for injection 114,3 mg/ml – according to Annex No. 2/5 to the SWZ; partial task No. 6 – Supply of Farycymab – according to Annex No. 2/6 to the SWZ; partial task No. 7 – Supply of Dexamethasonum – according to Annex No. 2/7 to the SWZ; partial task No. 8 – Supply of Teriflunomide – according to Annex No. 2/8 to the SWZ; partial task No. 9 – Supply of Dimethylis fumaras – according to Annex No. 2/9 to the SWZ; partial task No. 10 – Supply of Bevacyzumab – according to Annex No. 2/10 to the SWZ; partial task No. 11 – Supply of Zeposia – according to Annex No. 2/11 to the SWZ; partial task No. 12 – Supply of Copaxone – according to Annex No. 2/12 to the SWZ; partial task No. 13 – Supply of Kesimpta – according to Annex No. 2/13 to the SWZ; The offered product must have marketing authorization and a current registration certificate in accordance with the Act of 06.09.2001, Pharmaceutical Law (Journal of Laws 2020, item 944). Place of performance: Hospital Pharmacy at the SP ZOZ in Kędzierzyn – Koźle, ul. Roosevelta 2. The medicines offered must be included in the catalogue of reimbursed medicines used in drug programs constituting an annex to the order of the President of the National Health Fund, current as of the date of submission of tenders, on determining the conditions for concluding and performing contracts for hospital treatment in the scope of drug programs. partial task No. 1 – Supply of Ocrevus– according to Annex No. 2/1 to the SWZ; partial task No. 2 – Supply of Metalyse – according to Annex No. 2/2 to the SWZ; partial task No. 3 – Supply of Bevacyzumab – according to Annex No. 2/3 to the SWZ; partial task No. 4 – Supply of Aflibercept – solution for injection 40 mg/ml – according to Annex No. 2/4 to the SWZ; partial task No. 5 – Supply of Aflibercept – solution for injection 114,3 mg/ml – according to Annex No. 2/5 to the SWZ; partial task No. 6 – Supply of Farycymab – according to Annex No. 2/6 to the SWZ; partial task No. 7 – Supply of Dexamethasonum – according to Annex No. 2/7 to the SWZ; partial task No. 8 – Supply of Teriflunomide – according to Annex No. 2/8 to the SWZ; partial task No. 9 – Supply of Dimethylis fumaras – according to Annex No. 2/9 to the SWZ; partial task No. 10 – Supply of Bevacyzumab – according to Annex No. 2/10 to the SWZ; partial task No. 11 – Supply of Zeposia – according to Annex No. 2/11 to the SWZ; partial task No. 12 – Supply of Copaxone – according to Annex No. 2/12 to the SWZ; partial task No. 13 – Supply of Kesimpta – according to Annex No. 2/13 to the SWZ; Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.